Growth Hormone Therapy in Noonan's Syndrome: Non-Cardiomyopathic Congenital Heart Disease Does Not Adversely Affect Growth Improvement

Articles in the same Issue

1. TABLE OF CONTENTS
2. Development of the Hypothalamic-Pituitary-Adrenal Axis in the Fetus and Preterm Infant
3. Growth Hormone Signal Transduction
4. Growth-Promoting Actions of Prolactin, the Hormone of Lactation (see paper by Bujanover et al. on p. 789)
5. A Possible Role of Prolactin on Growth and Maturation of the Gut During Development in the Rat
6. Follow-up Height After Discontinuation of Growth Hormone Treatment in Ghildren with Intrauterine Growth Retardation
7. Familial Dysalbuminemic Hyperthyroxinemia: A Rare Example of Albumin Polymorphism and its Rapid Molecular Diagnosis
8. Responses of Bone Turnover Markers and Bone Mineral Density to Growth Hormone Therapy in Ghildren with Isolated Growth Hormone Deficiency and Multiple Pituitary Hormone Deficiencies
9. Borderline Gongenital Hypothyroidism in the Neonatal Period
10. Hot Nodules in Children and Adolescents in Western Poland from 1996 to 2000: Clinical Analysis of 31 Patients
11. Diabetes Mellitus-Related Autoantibodies in Childhood Autoimmune Hepatitis
12. Carnitine Metabolism in Diabetes Mellitus
13. Growth Hormone Therapy in Noonan's Syndrome: Non-Cardiomyopathic Congenital Heart Disease Does Not Adversely Affect Growth Improvement
14. An Adolescent with Food-Dependent Cushing's Syndrome Secondary to Ectopic Expression of GIP Receptor in Unilateral Adrenal Adenoma
15. Massive Ovarian Edema Causing Early Puberty
16. GAPO Syndrome: First Patients with Partially Empty Sella
17. BOOK REVIEWS. CALENDAR